ACHE and Alzheimer disease: Biological evaluation of the synthesised derivatives testing their anti-AChE inhibitory activity showed good results particularly for the acetylphrosporanyl derivative 8c which showed also promising results either in in vivo behavioural tests or in in silico studies makes it a newly discovered candidate for AD therapy that can be furtherly improved in future works.